AW
Ascend Wellness Holdings, Inc. (AAWH)·Q4 2024 Earnings Summary
Executive Summary
- Q4 2024 revenue was $136.0M (-4.0% q/q) as retail softened in IL/MI/NJ/MA amid pricing pressure; however, profitability improved with Adjusted EBITDA of $30.2M (22.2% margin, +450 bps q/q) and Adjusted Gross Margin of 41.9% (+410 bps q/q) as cost actions and mix shift helped margins .
- Cash generation was strong: Cash from Operations of $35.2M and Free Cash Flow of $30.1M, the eighth consecutive quarter of positive operating cash flow; year-end cash was $88.3M and Net Debt was $220.2M .
- Full-year 2024 revenue grew 8.3% to $561.6M and Adjusted EBITDA rose 9.1% to $116.2M (20.7% margin), with wholesale expansion offsetting retail pressure in certain states .
- Strategic/capital allocation: the company repurchased 11M shares in Q4 and launched a normal course issuer bid in Jan-2025 (up to ~5% of shares or $2.25M), repurchasing 620,500 shares subsequent to year-end; management emphasized densification (10 stores in development) and balance-sheet discipline .
- Estimate comparisons: Wall Street consensus from S&P Global was unavailable at the time of analysis due to an access limit; beats/misses vs estimates could not be assessed (will update when available).
What Went Well and What Went Wrong
-
What Went Well
- Margin execution outperformed internal expectations: Adjusted EBITDA of $30.2M (22.2% margin) and Adjusted Gross Margin of 41.9% driven by cost savings, better vertical mix, and production efficiencies; mgmt: “first full quarter with our new management team… improving profitability… and driving cash flow generation” .
- Robust cash generation and liquidity: Q4 Cash from Operations of $35.2M and FCF of $30.1M; year-end cash $88.3M and Net Debt $220.2M .
- Capital allocation and strategic positioning: 11M shares repurchased at a discount; NCIB initiated; densification strategy underway with ten stores in development (OH, PA, partner stores in IL/NJ); new effect-based brand (Effin’) gaining early traction .
-
What Went Wrong
- Top-line softness q/q: Q4 revenue fell 4.0% q/q to $136.0M as retail and third-party wholesale declined sequentially; retail decreased 3.5% to $90.4M and third‑party wholesale fell 5.0% to $45.6M .
- Retail headwinds in key markets: softness in IL/MI/NJ/MA driven by pricing pressure and volume, partially offset by OH adult-use ramp and new IL partner stores .
- Net loss persists (though improved q/q): Q4 net loss was $(16.8)M vs $(28.3)M in Q3; full-year net loss $(85.0)M largely due to absence of a $22.8M tax credit recognized in 2023 .
Financial Results
Consolidated P&L and Profitability
Notes: Q4 2024 sequential changes cited by the company: revenue -4.0% q/q; retail -3.5% q/q; wholesale -5.0% q/q; Adjusted EBITDA margin +450 bps q/q .
Segment Revenue (Quarterly)
KPIs and Balance Sheet
Full-year 2024: Revenue $561.6M (+8.3% y/y) and Adjusted EBITDA $116.2M (20.7% margin, +15 bps y/y) .
Guidance Changes
Earnings Call Themes & Trends
Note: The Q4 2024 earnings call transcript was not available in the document set; trends are derived from the company’s Q2–Q4 press releases.
Management Commentary
- CEO Sam Brill: “Improving profitability, maximizing asset efficiency, and driving cash flow generation… substantially completing our $30 million in annualized cost savings target… now turning to driving revenue growth… executing our densification strategy” .
- President Frank Perullo: “Focused on… consistent, high-quality products… densification strategy and transformation initiatives… well-positioned to thrive… lead as a premier operator” .
- CFO Roman Nemchenko: “450 bps sequential improvement in Adjusted EBITDA margin and $30.1M in Free Cash Flow… steps to rationalize inventory levels… strong start for our new leadership team” .
Q&A Highlights
- The Q4 2024 earnings call transcript was not available in the document set; Q&A themes and any guidance clarifications cannot be summarized at this time. The company held a conference call on March 12, 2025 at 5:00 p.m. ET .
Estimates Context
- S&P Global consensus estimates for Q4 2024 (EPS, revenue, EBITDA) were unavailable at the time of analysis due to an access limit; as a result, we cannot assess beats/misses versus Street for Q4 2024. We will update this section once S&P Global estimates can be retrieved.
Key Takeaways for Investors
- Margin/FCF inflection despite revenue softness: sequential margin expansion (Adjusted EBITDA margin +450 bps q/q) and $30.1M FCF signal cost program benefits and operating discipline .
- Retail remains pressured in IL/MI/NJ/MA; watch for stabilization and mix shift (vertical penetration) to sustain margin gains even if pricing remains competitive .
- Ohio adult-use and MA/NJ production efficiencies are tangible offsets; incremental densification and partner stores could re-accelerate revenue as 2025 progresses .
- Balance sheet trend is positive: cash up $23M q/q to $88.3M; Net Debt down to $220.2M; continued operating cash flow offers flexibility .
- Capital returns are now part of the story (11M shares repurchased; NCIB underway); execution against the cap allocation program will be a narrative driver .
- Wholesale momentum is mixed (IL/NJ down, MA improving); state-level dynamics remain key to near-term revenue trajectory .
- FY24 delivery vs Q2 guidance: revenue growth below the +11–13% range, EBITDA growth within +5–10%, and CFO materially above >$40M; directionally supportive for credibility on cost/FCF targets, with top-line recovery the next focus .
Sources
- Q4 2024 (8-K 2.02 press release and financial schedules): **[1756390_0001628280-25-012342_awhq42024pressrelease.htm:0]** **[1756390_0001628280-25-012342_awhq42024pressrelease.htm:1]** **[1756390_0001628280-25-012342_awhq42024pressrelease.htm:2]** **[1756390_0001628280-25-012342_awhq42024pressrelease.htm:3]** **[1756390_0001628280-25-012342_awhq42024pressrelease.htm:4]** **[1756390_0001628280-25-012342_awhq42024pressrelease.htm:5]** **[1756390_0001628280-25-012342_awhq42024pressrelease.htm:6]** **[1756390_0001628280-25-012342_awhq42024pressrelease.htm:8]** **[1756390_0001628280-25-012342_awhq42024pressrelease.htm:9]** **[1756390_0001628280-25-012342_awhq42024pressrelease.htm:10]** **[1756390_0001628280-25-012342_awhq42024pressrelease.htm:11]**
- Q3 2024 (8-K 2.02 press release and financial schedules): **[1756390_0001628280-24-046851_ex991awhq32024pressrelease.htm:0]** **[1756390_0001628280-24-046851_ex991awhq32024pressrelease.htm:1]** **[1756390_0001628280-24-046851_ex991awhq32024pressrelease.htm:2]** **[1756390_0001628280-24-046851_ex991awhq32024pressrelease.htm:5]** **[1756390_0001628280-24-046851_ex991awhq32024pressrelease.htm:6]** **[1756390_0001628280-24-046851_ex991awhq32024pressrelease.htm:7]**
- Q2 2024 (8-K 2.02 press release and financial schedules): **[1756390_0001628280-24-034523_awhq22024pressrelease.htm:0]** **[1756390_0001628280-24-034523_awhq22024pressrelease.htm:1]** **[1756390_0001628280-24-034523_awhq22024pressrelease.htm:2]** **[1756390_0001628280-24-034523_awhq22024pressrelease.htm:5]** **[1756390_0001628280-24-034523_awhq22024pressrelease.htm:6]** **[1756390_0001628280-24-034523_awhq22024pressrelease.htm:7]**